IRESite record type: plasmid_with_promoter_and_putative_IRES_translationally_characterized
The shape of the nucleic acid molecule translated: linear
The quality of the mRNA/+RNA sequence: both_UTRs_incomplete
The mRNA/+RNA description:
5'-end truncated 5'-UTR (234-395 bp of original sequence) of c-myc mRNA transcribed from major P2 promotor,
where the first 233 bases were removed. Insert was cloned into pGL3R vector between renilla and firefly
luciferase.
The mRNA/+RNA sequence represented in the +DNA notation:
Credibility of mRNA sequence: unknown
The name of the plasmid: pGL3Rutr234-395
The name of the promoter used to express this mRNA: SV40
The in vivo produced transcripts are heterogeneous (due to any of promoter?/splicing?/cleavage?/breakage?): not tested
The in vivo produced heterogeneous transcripts occur due to alternative splicing: not tested
A promoter reported in cDNA corresponding to IRES sequence: not tested
The abbreviated name of the donor gene or virus from which this IRES was excised and inserted into the plasmid: c-myc
The relative translation efficiency in % of this IRES: 9.000
Name of IRES used as the positive control: c-myc
Name of the plasmid used as the positive control. pGL3Rutr
IRESite Id of the plasmid used as positive control. 25
The relative translation efficiency in % of the positive control: 100.000
The size (length) of intercistronic region in the positive control: 450
The effect of 5'-cap analogs on translation: not tested
Rapamycin affects translation: not tested
Type of RNA subject to translation: endogenous_nuclear_RNA_Pol_II_transcript
Remarks:
As a positive control was used HeLa cell line transformed by vector pGL3Rutr, which contains full-length 5'UTR
of c-myc P2 transcript inserted between renilla and firefly luciferase.